Linvesta Emp 25mg/5mg Tablet
₨ 558
About this product
Overview
Linvesta Emp 25mg/5mg Tablet is a combination medication that contains two active ingredients: EMPAGLIFLOZIN + LINAGLIPTIN It is commonly prescribed for the management of type 2 diabetes mellitus by providing dual-action control over blood glucose levels.
Active Ingredients
- Empagliflozin (25mg):
- Empagliflozin belongs to the class of sodium-glucose co-transporter-2 (SGLT2) inhibitors, which work by reducing the reabsorption of glucose by the kidneys, leading to increased glucose excretion in the urine.
- Linagliptin (5mg):
- Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which enhances the secretion of insulin and helps reduce the production of glucose in the liver.
Used For
- Type 2 Diabetes Mellitus: Linvesta Emp is used for the management of type 2 diabetes mellitus to improve blood sugar control.
- Dual-Action Control: It provides dual-action control over blood glucose levels by reducing glucose reabsorption and increasing insulin secretion.
Dosage and Administration
- The dosage is typically determined by healthcare providers based on individual response and medical condition.
- Tablets are usually taken orally, with or without food, as directed by the healthcare provider.
Side Effects
Common side effects may include urinary tract infections, increased urination, and hypoglycemia (low blood sugar). It is important to report any severe or persistent side effects to a healthcare professional.
When Not to Use
- Type 1 Diabetes: Linvesta Emp is not indicated for the treatment of type 1 diabetes.
- Severe Renal Impairment: It is contraindicated in individuals with severe renal impairment or end-stage renal disease.
Precautions and Warnings
- Dehydration: Use with caution in individuals at risk of dehydration, such as elderly patients or those taking diuretics.
- Pancreatitis: Monitor for signs and symptoms of pancreatitis, as it has been reported with DPP-4 inhibitors.
Other brands of EMPAGLIFLOZIN + Linagliptin
These medicines also contain EMPAGLIFLOZIN + Linagliptin, but in a different strength or pack. Do not switch to a different strength without asking your doctor.
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Glem Lin 10/5mg Tablet | Nabiqasim Industries | 10/5mg | Rs 360 |
| Linvesta Emp 10mg/5mg Tablet | Wilshire Laboratories | 10mg/5mg | Rs 377 |
| Empaa L 25/5 mg Tablet | Weather Fold Pharmaceuticals | 25/5mg | Rs 429.94 |
| Emsyn Lee 5/10mg Tablet | Searle Company | 5/10mg | Rs 453 |
| Empagen L 5/10mg Tablet | Ferozsons Laboratories | 5/10mg | Rs 454 |
| Xenglu Lin 10/5mg Tablet | Hilton Pharma | 10/5mg | Rs 520 |
| Linvesta Emp 25/5mg Tablet | Wilshire Laboratories | 25/5mg | Rs 558 |
| Erlina 10/5mg Tablet | Pharmevo | 10/5mg | Rs 575 |
Frequently asked questions
How does Linvesta Emp 25mg/5mg Tablet help manage type 2 diabetes?
Linvesta Emp combines Empagliflozin and Linagliptin, working together to reduce glucose reabsorption by the kidneys and enhance insulin secretion, thereby improving blood sugar control.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.